Atlantic Capital Bancshares, Inc. Announces Extension of Exchange Offer

ATLANTA, Dec. 04, 2020 (GLOBE NEWSWIRE) — Atlantic Capital Bancshares, Inc. (NASDAQ: ACBI) (“Atlantic Capital”) announced today that it extended its offer to holders of $75 million in aggregate principal amount of its 5.5% fixed to floating rate subordinated notes due 2030 (the “Old Notes”), issued August 20, 2020, to exchange the Old Notes for a like principal amount of notes with identical terms other than that such new notes have been registered under the Securities Act of 1933, as amended.

The exchange offer, which had been scheduled to expire on December 2, 2020 at 11:59 p.m., New York City time, will now expire at 5:00 p.m., New York City time, on December 10, 2020, unless further extended by Atlantic Capital. All other terms, provisions and conditions of the exchange offer will remain in full force and effect. US Bank National Association is serving as exchange agent for the exchange offer.

Atlantic Capital said it has been informed by the exchange agent that, as of December 3, 2020 at 9:00 a.m., New York City time, $73,500,000 in aggregate principal amount of the Old Notes had been tendered in the exchange offer. This amount represents approximately 98% of the Old Notes.

This press release is for informational purposes only and does not constitute an offer to sell or the solicitation to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

The indebtedness evidenced by the notes is not a deposit and is not insured by the Federal Deposit Insurance Corporation or any other government agency or fund.

About Atlantic Capital Bancshares

Atlantic Capital Bancshares, Inc. is a $2.9 billion publicly traded bank holding company headquartered in Atlanta, Georgia. Atlantic Capital offers commercial and not-for-profit banking services, specialty corporate financial services, private banking services and commercial real estate finance solutions to privately held companies and individuals in the Atlanta area, as well as specialized financial services for select clients nationally.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements represent plans, estimates, objectives, goals, guidelines, expectations, intentions, projections and statements of our beliefs concerning future events, business plans, objectives, expected operating results and the assumptions upon which those statements are based. Forward-looking statements include without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and are typically identified with words such as “may,” “could,” “should,” “will,” “would,” “believe,” “anticipate,” “estimate,” “project,” “expect,” “intend,” “plan,” “strive,” or words or phases of similar meaning. Forward-looking statements are based largely on Atlantic Capital’s expectations and are subject to a number of known and unknown risks and uncertainties that are subject to change based on factors which are, in many instances, beyond Atlantic Capital’s control. These risks, uncertainties and other factors may cause the actual results, performance, and achievements of the Company to be materially different from the anticipated future results, performance or achievements expressed in, or implied by, the forward-looking statements. Factors that could cause such differences include, but are not limited to, general economic conditions, the impact of the COVID-19 pandemic, changes in interest rates, regulatory considerations, competition and market expansion opportunities, changes in non-interest expenditures or in the anticipated benefits of such expenditures, the receipt of required regulatory approvals, and changes in tax laws. Atlantic Capital undertakes no obligation to publicly update any forward-looking statement to reflect developments occurring after the statement is made, except as otherwise required by law. Actual results, performance or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements as a result of, among other factors, the risks and uncertainties described in “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Atlantic Capital’s Annual Report on Form 10-K, as supplemented by our Current Report on Form 8-K filed on April 23, 2020, and Quarterly Reports on Form 10-Q. Please refer to the SEC’s website at www.sec.gov where you can review those documents.

Contact:

Patrick Oakes, Executive Vice President and CFO
Email: [email protected] 
Phone: 404-995-6050



IIROC Trading Halt – EGTI

Canada NewsWire

VANCOUVER, BC, Dec. 4, 2020 /CNW/ – The following issues have been halted by IIROC:

Company: EYEFI Groupe Technologies Inc.

CSE Symbol: EGTI

All Issues: Yes

Reason: Pending News

Halt Time (ET): 9:27 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

IIROC Trade Resumption – SZLS.WS

Canada NewsWire

TORONTO, Dec. 4, 2020 /CNW/ – Trading resumes in:

Company: StageZero Life Sciences Ltd.

TSX Symbol: SZLS.WS

All Issues: No

Resumption (ET): 9:30 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

INVESTIGATION ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm – INFO, CIT, RESI

NEW YORK, Dec. 04, 2020 (GLOBE NEWSWIRE) — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:


IHS Markit Ltd. (NYSE: INFO)
concerning potential violations of law relating to its sale to S&P Global Inc. Under the terms of the merger agreement, each share of IHS Markit common stock will be exchanged for a fixed ratio of 0.2838 shares of S&P Global common stock. If you are an IHS Markit shareholder, click here to learn more about your rights and options.


CIT Group


Inc. (


NYSE:


CIT


)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to First Citizens BancShares, Inc. Under the terms of the merger agreement, CIT shareholders will receive 0.0620 shares of First Citizens class A common stock for each share of CIT common stock they own. If you are a CIT Group shareholder, click here to learn more about your rights and options.


Front Yard Residential Corporation (NYSE:


RESI


)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to a partnership led by Pretium and funds managed by Ares Management Corporation for $16.25 per share. If you are a Front Yardshareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]



Thinking about trading options or stock in Moderna, Exxon Mobil, American Airlines, Blink Charging, or Ambarella?

PR Newswire

NEW YORK, Dec. 4, 2020 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for MRNA, XOM, AAL, BLNK, and AMBA.

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report – Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report – Measures a stock’s suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street’s opinion including a 12-month price forecast.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-moderna-exxon-mobil-american-airlines-blink-charging-or-ambarella-301186543.html

SOURCE InvestorsObserver

Thinking about buying stock in Spirit Airlines, Infinity Pharmaceuticals, Johnson & Johnson, BP, or Carnival Corp?

PR Newswire

NEW YORK, Dec. 4, 2020 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for SAVE, INFI, JNJ, BP, and CCL.

To see how InvestorsObserver’s proprietary scoring system rates these stocks, view the InvestorsObserver’s PriceWatch Alert by selecting the corresponding link.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver’s PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock’s overall suitability for investment.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-spirit-airlines-infinity-pharmaceuticals-johnson–johnson-bp-or-carnival-corp-301186539.html

SOURCE InvestorsObserver

Thinking about trading options or stock in Norwegian Cruise Line, Pfizer, General Electric, Walt Disney, or Intel Corp?

PR Newswire

NEW YORK, Dec. 4, 2020 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for NCLH, PFE, GE, DIS, and INTC.

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report – Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report – Measures a stock’s suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street’s opinion including a 12-month price forecast.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-norwegian-cruise-line-pfizer-general-electric-walt-disney-or-intel-corp-301186533.html

SOURCE InvestorsObserver

Daiki Axis Co., Ltd. (4245, Tokyo) Overview of Operating Performance for the Nine Months Ended September 30, 2020

In the nine months ended September 30, 2020, operating income and ordinary income increased. The renewable energy segment grew substantially, becoming a stable source of earnings.

PR Newswire

TOKYO, Dec. 4, 2020 /PRNewswire/ —

Summary of Results

The business environment surrounding the Company deteriorated during the nine months ended September 30, 2020 due to the rapid global spread of the novel coronavirus pandemic (COVID-19). Meanwhile, the industry was also impacted by the spread of COVID-19 as restrictions on sales activities resulted in order booking delays.

Under these circumstances, the Company is promoting a strategy focused on improving future profitability. In the environmental equipment segment, the Company pursued overseas business development and strengthened sales in the recurring-revenue energy service company (ESCO) business in the areas of maintenance and water. At the same time, in the household equipment-related business segment, the Company engaged in efforts aimed at transitioning from stability in business to growth, including the launch of an e-commerce business. Additionally, in the renewable energy segment, the Company conducted initiatives targeting the achievement of a recycling-oriented society and enhanced stable income-generating capabilities.

Net sales in the nine months ended September 30, 2020 were JPY25,687 million (down 3.4% YoY). However, thanks to measures to improve comprehensive income, gross profit came to JPY5,430 million (up 6.2% YoY) while operating income closed at JPY830 million (up 9.9% YoY) and ordinary income was JPY961 million (up 12.3% YoY). In terms of extraordinary gains and losses, the Company recorded a gain of JPY152 million on sales of subsidiaries and a JPY236 million impairment loss. The Company has been recording an annual preferred dividend of 4.8% paid to holders of classified stock in consolidated subsidiary Sylphid Inc. since the third quarter of the fiscal year ended March 31, 2019, which had an impact on profit attributable to non-controlling interests. Consequently, profit attributable to owners of parent amounted to JPY335 million (down 21.2% YoY) in the nine months ended September 30, 2020.

In the environmental equipment segment, sales of wastewater treatment systems were down year on year. The Company recorded a measurable amount of domestic sales from large-scale projects in the nine months ended September 30, 2019. However, sales in the nine months ended September 30, 2020 did not measure up to this amount, and overseas sales were affected substantially by a deteriorating business climate caused by the COVID-19 pandemic. Sales in the recurring-revenue energy service company (ESCO) business in the area of maintenance were strong but remained level year on year in the recurring-revenue ESCO business in the area of water despite an increase in contracts due primarily to a decrease in customer water usage. Consequently, sales in the environmental equipment segment were JPY12,743 million (down 8.6% YoY) while operating income was JPY798 million (up 15.0% YoY).

In the household equipment-related business segment, construction-related sales were impacted by product shipment delays that arose because many suppliers associated with these sales have component production sites in China, but the Company was able to deal with this impact by substituting alternative products. Sales were also strong when compared to the nine months ended September 30, 2019 due to replacement demand for store equipment and other facilities. In terms of residential machinery construction, the Company was involved in a large-scale new store construction project, but medium- to large-scale projects were scarce overall. Despite this project scarcity, the Company benefitted from sales generated by Fujiwara Reiki, which became a consolidated subsidiary in October 2019, and overall residential machinery construction sales were strong compared to the nine months ended September 30, 2019. Sales of retail products through DIY stores were impacted by lower sales to existing stores, and sales activities in the EC business, including field surveys targeting end users, were delayed due to the spread of the novel coronavirus pandemic. As a result, sales in the household equipment-related business segment were JPY11,109 million (up 4.5% YoY), and operating income was JPY299 million (down 7.3% YoY).

In the renewable energy segment, through its solar power sales business, the Company has been renting roof space on DCM Group stores since FY2018. Within this space, it has constructed power generation facilities and sold electricity under a feed-in tariff (FIT) system. In the nine months ended September 30, 2020, the Company began selling electricity from six more facilities, and sales increased substantially year on year as a result. According to the Company’s plans, only two facilities that have not yet begun selling electricity remain. Meanwhile, sales declined year on year both the biodiesel fuel and compact wind generation businesses. Consequently, sales in the renewable energy segment were JPY690 million (up 34.3% YoY), and operating income was JPY282 million (up 39.7% YoY).

In other segments, sales in the engineering business fell substantially year on year due to the sale of DAD Co., Ltd. at the end of the six-month period ended June 30, 2020. In the household drinking water business, sales were strong compared to the nine months ended September 30, 2019. As a result, sales in other segments were JPY1,143 million (down 23.8% YoY) and operating income was JPY144 million (up 10.9% YoY).

In terms of financial status, the Company’s liquid assets, non-current assets, and current liabilities declined due to the transfer of all shares in DAD Co., Ltd. at the end of the six-month period ended June 30, 2020. Meanwhile, noncurrent liabilities increased as the Company issued green bonds (unsecured bonds available only to qualified institutional investors) with the goal of conducting capital investment in the business of selling power from solar power facilities and the compact wind generation business.

The Company has released its consolidated results forecast for the fiscal year ending December 31, 2020. The forecast projects net sales of JPY34,400 million (down 3.8% YoY), operating income of JPY1,010 million (up 0.9% YoY), ordinary income of JPY1,160 million (up 0.4% YoY), profit attributable to owners of parent of JPY550 million (down 29.7% YoY), and EPS of JPY44.32.

Daiki Axis Co., Ltd. (4245, First Section, TSE http://www.daiki-axis.com/english/)
“Summary of Consolidated Financial Results for the Nine Months Ended September 30, 2020” is available here:
http://www.daiki-axis.com/ir/info/index09.html

Release Disclaimer
This release is for the purpose of providing information to serve as a reference for investment decisions and not for the purpose of soliciting investment. Please exercise your own judgment on final decisions such as investment policy, timing and selection. Please be advised that we do not assume any responsibility for damages caused by this service.

Release Inquiries
Borderless IR Co., Ltd. http://b-ir.co.jp/english/main.php
Sixth Floor, Toyo Building 1-2-10 Nihonbashi, Chuo-ku, Tokyo 103-0027 JAPAN
TEL: +81-3-4588-6706 POC: Toru Fukuda
Contact form: http://b-ir.co.jp/english/contact.php

Borderless IR specializes in the global distribution of IR content, including the dissemination of newsletters and annual reports providing the latest information and main strengths of Japanese companies directly to overseas investors through leading global media, corporate information database services and mailing lists. Borderless is also engaged in supporting other global IR efforts.

©Borderless IR Co., Ltd. All rights Reserved

The content of this release may not be duplicated or reproduced.

 

Cision View original content:http://www.prnewswire.com/news-releases/daiki-axis-co-ltd-4245-tokyo-overview-of-operating-performance-for-the-nine-months-ended-september-30-2020-301186389.html

SOURCE Daiki Axis Co., Ltd.

Sabine Royalty Trust Announces Monthly Cash Distribution For December 2020

PR Newswire

DALLAS, Dec. 4, 2020 /PRNewswire/ — Simmons Bank, as Trustee of the Sabine Royalty Trust (NYSE: SBR), today declared a cash distribution to the holders of its units of beneficial interest of $0.124040 per unit, payable on December 29, 2020, to unit holders of record on December 15, 2020.  Sabine’s cash distribution history, current and prior year financial reports and tax information booklets, a link to filings made with the Securities and Exchange Commission and more can be found on its website at http://www.sbr-sabine.com/.  Additionally, printed reports can be requested and are mailed free of charge.

During the month of November, the respective shelter-at-home/work-from-home orders across the spectrum of the industry has significantly affected the posting of revenues for the Trust, until the following month of November.  As adjustments are made accordingly, the functions of the Trust are still being performed, although on a delayed basis.  We will continue to strive to make the operations of the Trust and its providers, as fluid as possible.

Also, the impact of the precipitous drop in energy pricing are not reflected in this month’s revenue, however it has been seen in the previous months.  With the assets of the Royalty Trust being almost true royalty interest ownership of established production streams, production should continue, however the over-supply of existing industry inventories will affect the ability to transport on down the production stream. As the result of these aforementioned factors, various producers/operators/purchasers may not be able to continue as they have been and could affect payment to the Trust.  We are taking steps to monitor those various entities as they have a direct relationship with the Trust.  The ownership of the Trust’s various royalty interests should not be diminished, as that will continue.

This distribution reflects primarily the oil production for September 2020 and the gas production for August 2020.  Preliminary production volumes are approximately 49,182 barrels of oil and 761,607 Mcf of gas.  Preliminary prices are approximately $38.40 per barrel of oil and $1.68 per Mcf of gas.

The table below compares this month’s production and prices to the previous month’s:

Net to Trust Sales

Volumes

Average Price

Oil
(bbls)

Gas
(Mcf)

Oil

(per bbl)

Gas

(per Mcf)

Current Month

49,182

761,607

$38.40

$1.68

Prior Month

54,132

619,545

$37.23

$1.45

Revenues are only distributed after they are received, verified and posted.  Most energy companies normally issue payment of royalties on or about the 25th of every month, and depending on mail delivery, a varying amount of royalties are not received until after the revenue posting on the last business day of the month.  The revenues received after that date will be posted within 30 days of receipt.

Due to the timing of the end of the month of November, approximately $671,000 of revenue received will be posted in the following month of December in addition to normal receipts during December.  Since the close of business in November and prior to this press release, there has been approximately $555,000 in revenue received.

Approximately $722,000 for 2020 Ad Valorem taxes was deducted from this month’s distribution as compared to $922,000 this time last year.  These payments are normal expenditures at this time of year.

The 2020 tax information packets are expected to begin mailing directly to unitholders in early March 2021.  A copy of Sabine’s 2020 tax information booklet will be posted on Sabine’s website by March 1, 2021.  In addition to the tax booklet the Sabine website will also offer two simple calculators for computing the income and expense amounts and the cost depletion.  The calculators are currently expected to be updated with the 2020 tax information by February 26, 2021.

The 2019 Annual Report with Form 10-K and the January 1, 2020 Reserve Summary is available on the Sabine website at http://www.sbr-sabine.com/. 

Cision View original content:http://www.prnewswire.com/news-releases/sabine-royalty-trust-announces-monthly-cash-distribution-for-december-2020-301186555.html

SOURCE Sabine Royalty Trust

Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare

Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare

Clinical-stage company is focused on innovation in skin health worldwide

TORONTO–(BUSINESS WIRE)–MedC Biopharma Corporation (“MedC”), a science-driven company that develops, produces and delivers innovative skin oncology medication worldwide, has announced the launch of its $3 million private placement offering using the DealSquare platform, powered by NEO and DealMaker technology.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201204005071/en/

MedC Biopharma Corporation (“MedC”), a science-driven company that develops, produces and delivers innovative skin oncology medication worldwide, participates in a digital market open to celebrate its private placement offering on DealSquare. (Photo: Business Wire)

MedC Biopharma Corporation (“MedC”), a science-driven company that develops, produces and delivers innovative skin oncology medication worldwide, participates in a digital market open to celebrate its private placement offering on DealSquare. (Photo: Business Wire)

A clinical-stage biopharmaceutical company, MedC ($MEDCB) develops and commercializes cannabinoid and other natural compound-containing products for use in the consumer, veterinary, medical skin, and general health markets. The company has already developed two drugs toward clinical trials for CTCL – Skin (Cutaneous) T-cell Lymphoma and Cutaneous Leishmaniasis, both of which are recognized as orphan conditions with unmet needs, and as markets with huge potential. MedC is developing its own proprietary red sea-algae “Algel” gel-based products, with a variety of applicable uses for skin health and wellness, and is also pursuing opportunities in veterinary medication and pet health, specifically oncology and inflammation-related indications (an estimated $400 million annual market).

MedC’s campaign marks the first capital raise through the joint service offering between DealSquare and DealMaker. DealSquare, powered by NEO, is a fully automated and centralized platform allowing capital raisers to publish their private placement opportunities, dealers to complete their due diligence, and advisors and investors to electronically subscribe to a deal. DealMaker provides the back-office technology, transaction engine, and electronic signature functionality for investors submitting orders electronically, compliantly, globally. Together, DealSquare, NEO, and DealMaker provide MedC with the smoothest transaction experience and broadest reach of capital market participants.

“The launch of our private offering leveraging the joint service capabilities of these reputable platforms marks a significant step towards MedC taking its place amongst industry leaders that are determined to legitimize and deliver the health benefits of cannabinoids to the global community,” remarked Dr. Owen Van Cauwenberghe, President of MedC. “Our tireless efforts and commitment to substantiated medical and health claims for these products will ensure that their benefits will be available to all those in need. We are fortunate to be able to take advantage of the combined DealSquare, NEO, and DealMaker offering.”

MedC’s listing on DealSquare, combined with the technology of DealMaker, creates an opportunity for investors who believe there is a global need to mature and legitimize the cannabis and cannabis-related health and medical market, by supporting the development of products that deliver health and wellness benefits. With the funds raised from the campaign, MedC is targeting international expansion, initially across Canada and Australia, with plans to launch in Europe, UK, Asia, and Latin America shortly thereafter. It will also expand its product offering with new lines for different markets and multiple dose formats. There will be a strong focus on research and development of high value market products, as well as regulatory work, thus enabling MedC to further enhance its product offering.

“We welcome MedC as our first partner in the joint initiative we have launched with DealMaker,” said Peter-Paul Van Hoeken, Managing Director of DealSquare. “The cannabis-related health and medical sector is a fast-growing market that offers attractive investment opportunities. The MedC listing enables dealers and advisors to offer this investment opportunity to their clients, and to execute investments efficiently and in a fully digitized way through our online platform.”

“MedC is well-positioned to deliver effective medical treatments for skin conditions in a highly underserviced market, and the funds raised from this joint campaign will help make that possible,” added Rebecca Kacaba, CEO of DealMaker. “We are honoured to be powering MedC in raising the capital needed to achieve rapid growth.”

“MedC’s capital raise is truly a noteworthy event,” concluded Jos Schmitt, President and CEO of NEO. “It marks the coming together of like-minded organizations, all of whom are on a relentless pursuit of innovation for the benefit of others. By harnessing the combined strength of DealMaker and DealSquare, powered by NEO, MedC gains exposure to a wider investor community, both here in Canada and abroad.”

To view MedC Biopharma’s private placement offering on DealSquare, click here. For direct investor investment, click here. The MedC Biopharma ticker is available under MEDCB on existing advisor order entry systems.

About MedC Biopharma

MedC Biopharma is a science-driven company focused on developing, producing, and delivering differentiated cannabinoid and other natural compound-containing products targeting the consumer, veterinary and medical skin & general health markets.

Connect with MedC Biopharma: Website | LinkedIn

About DealSquare

A joint initiative between NEO and Silver Maple Ventures, DealSquare, is Canada’s first centralized dealer platform for private placements, digitally connecting capital-raisers to investment dealers, their advisory networks, and their investors. With the complete roll-out of the platform in early 2020, DealSquare supports the entire private placement process: capital raisers publish their private placement opportunities; dealers complete their due diligence; and advisors electronically subscribe to a deal, with exempt securities seamlessly integrated into client accounts and back office systems utilizing NEO technology.

Connect with DealSquare: Website | LinkedIn | Twitter

About DealMaker

DealMaker is an innovative cloud-based platform for the capital raising and settlement of domestic and international private placements in capital markets, KYC and Fund Formation. DealMaker makes private placement transactions surprisingly pleasant, delivering speed, innovation, and efficiency to the global private capital markets. Financings using DealMaker close faster, with greater control over the process which creates a better experience. DealMaker strives for a simpler, cleaner way of doing things on one global platform.

Connect with DealMaker: Website | LinkedIn | Twitter

About NEO

NEO is a group of established fintech companies that provide capital markets infrastructure designed for and led by the industry. NEO’s competitive drive, innovation, and advocacy enable change for the better. The NEO Exchange is a progressive stock exchange that brings together investors and capital raisers within a fair, efficient, and service-oriented environment; and DealSquare, powered by NEO technology, is a platform that enables the distribution of financial assets not listed on a stock exchange in a way that reduces costs, minimizes operational risks, and improves the investor experience.

Connect with NEO: Website | Twitter| LinkedIn

Media Contact:

DealSquare

John Hills

E: [email protected]

P: 289 962 1708

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Technology Research Clinical Trials Biotechnology Networks Health Data Management Other Science Science

MEDIA:

Logo
Logo
Photo
Photo
MedC Biopharma Corporation (“MedC”), a science-driven company that develops, produces and delivers innovative skin oncology medication worldwide, participates in a digital market open to celebrate its private placement offering on DealSquare. (Photo: Business Wire)